Pharming Group N.V. (PHAR)

NGM – Real Time Price. Currency in USD

13.09

+0.47 (3.69%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

377M

297M

246M

206M

Cost of goods sold

-56M

-46M

-36M

-22M

Gross Profit

321M

250M

209M

184M

Operating expenses (excl. COGS)

-300M

-254M

-231M

-180M

Operating Income

21M

-4M

-22M

Non-operating income, total

-9M

-3M

10M

12M

Pretax income

12M

-7M

-12M

16M

Equity in earnings

625K

-2M

-289K

-1M

Taxes

-10M

-3M

-1M

Non-controlling/minority interest

314K

After tax other income/expense

Net income before discontinued operations

-12M

-11M

14M

Pharming Group N.V. (PHAR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Pharming Group N.V. (PHAR)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Pharming Group N.V. (PHAR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Pharming Group N.V. (PHAR)

Income Statement (Annual)

Income Statement (Annual)